siOPTICA GmbH from Jena has secured growth financing with beteiligungsmanagement thüringen GmbH (bm|t) and Capital-E II ARKIV (Capital-E), based in Antwerp, with a volume of more than €4m. With the fresh capital, siOPTICA will be able to extend their product range of switchable privacy filters, expand their protective rights portfolio, adapt existing solutions to new requirements of customers, and further develop innovative privacy technology generations.
Technologiegründerfonds Sachsen (TGFS) and GPS Ventures GmbH invest €2m in NAVENTIK GmbH from Chemnitz (www.naventik.de). The company NAVENTIK was founded in January 2017 and has developed the “PATHFINDER” technology, a software-based technology for satellite-assisted localisation (GNSS) of vehicles in order to come one decisive step closer to the goal of driverless cars.
TGFS (Technologiegründerfonds Sachsen, www.tgfs.de) is investing a large six-figure seed financing amount in Raylytic GmbH (www.raylytic.com), which is specialised in the computer-aided, high-precision analysis of X-ray, CT, and MRI images.
RedAnts GmbH, Bremen, one of the leading industry service providers in Germany in the field of the quality management of production processes, will transfer their headquarters from the Hanseatic city to Leipzig in 2018. This move is contemplated by the contractual agreement on a minority shareholding of S-Beteiligungen, Leipzig, in the RedAnts company group, which is mainly active in the automotive industry.
Euronext-listed Eckert & Ziegler BEBIG which is active in the medical devices segment of the healthcare industry, has acquired St. Gangloff (Thuringia, Germany) based WOLF-Medizintechnik GmbH.
TGFS (Technologiegründerfonds Sachsen) and High-Tech Gründerfonds (HTGF) invest in the future of FlyNex GmbH (www.flynex.de). The DroneTech company closes a seven-digit seed round and is going to extend its offices in Leipzig and Hamburg.
Clinical Innovations, Inc., one of the largest medical device companies exclusively focused on labor and delivery and the neonatal intensive care unit, has acquired Brenner Medical GmbH through its wholly owned subsidiary, Clinical Innovations Europe. The acquisition in central Europe broadens Clinical Innovations’ infrastructure in Europe and overall global presence.
Ströer has acquired 75 percent of the Avedo group from the previous shareholders Seafort Advisors and Onics. The founder and managing director of Avedo remains a 25 percent shareholder through his equity investment company Onics, while Seafort completely withdraws as a shareholder.
Multidisziplinär – mit herausragender Branchenkenntnis